Fact CheckerSign in

NCT05208671Completed

Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

The NOURISH-OK Study will identify how food insecurity contributes to insulin resistance, an important surrogate marker of many co-morbidities in HIV disease, using an integrated framework to identify key leverage points for insulin resistance. Drawing from these pathways, this study will adapt and evaluate a community-driven, science-informed "food as medicine" intervention designed to lower insulin resistance through healthy food access, food utilization skills, and other self-care behaviors. Knowledge gained from this study can benefit those living with HIV through the prevention and more effective management of pre-diabetes, diabetes, obesity, and non-alcoholic fatty liver disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
675 (actual)
First submitted
11 Jan 2022
Start date
Oct 2020
Primary completion date
Oct 2025
Lead sponsor
University of Oklahoma
Diseases
HIV
NCT number
NCT05208671

What you commit to

  • Study type: Interventional
  • Participants enrolled: 675
  • From Oct 2020 to the primary completion date, Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • receiving treatment for a terminal or other serious illness, such as cancer or end-stage renal failure

Other

  • participating in another health-related research study
  • plan to move outside of Oklahoma during the study period
  • does not have an address that can accept home-delivered groceries

Who the study is looking for

  • HIV-positive with income \<400% federal poverty level
  • at least 1 risk factor for insulin resistance per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (i.e., overweight/obesity, age 45 yrs or older, immediate family member with diabetes, non-white race, physical inactivity, history of gestational diabetes, history of heart disease or stroke, diagnosis of polycystic ovarian syndrome, high blood pressure, high cholesterol, or hepatitis C virus antibody positivity
  • using antiretroviral therapy for at least 6 months
  • English-speaking

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
OU Integrative Immunology Center
Coordinator of this site? Confirm its status
TulsaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.